{"created":"2023-05-15T09:06:53.303853+00:00","id":13972,"links":{},"metadata":{"_buckets":{"deposit":"986de68b-362d-4257-a17f-a8405c76f4e2"},"_deposit":{"created_by":14,"id":"13972","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"13972"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00013972","sets":["1875:1879:2066"]},"author_link":["22497","22498","22499","22500","22501","22502","22503","22504"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-10-31","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"15","bibliographicPageStart":"13","bibliographicVolumeNumber":"41","bibliographic_titles":[{"bibliographic_title":"函館医学誌 = Hakodate medical journal"},{"bibliographic_title":"Hakodate medical journal","bibliographic_titleLang":"en"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Ｃ型慢性肝疾患に対して，平成23年11月Direct Acting Antivirals（DAA）が登場し，それまでの標準治療であったインターフェロン（IFN）/リバビリン（RBV）療法と併用することで，治療効果が飛躍的に向上した１）。平成26年９月からは，IFN と併用しないIFN free 療法も可能となり，治療対象が大幅に拡大された２）。今回，IFN free 療法の治療成績について検討したので報告する。","subitem_description_type":"Abstract"}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"市立函館病院"}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0910-0725","subitem_source_identifier_type":"ISSN"}]},"item_2_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"山本, 義也"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"北潟谷, 隆"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"霜田, 佳彦"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"伊藤, 淳"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"大野, 正芳"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"工藤, 大樹"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"畑中, 一映"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"成瀬, 宏仁"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-04-08"}],"displaytype":"detail","filename":"n0910072541113.pdf","filesize":[{"value":"1.7 MB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"n0910072541113","url":"https://sapmed.repo.nii.ac.jp/record/13972/files/n0910072541113.pdf"},"version_id":"25ad5e84-69f0-4257-9e70-c8adf388184d"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"hepatitis C","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"direct acting antivirals","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"当院におけるGenotype1b 型Ｃ型慢性肝疾患に対するインターフェロンフリー療法の治療成績","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"当院におけるGenotype1b 型Ｃ型慢性肝疾患に対するインターフェロンフリー療法の治療成績","subitem_title_language":"ja"},{"subitem_title":"Effectiveness of Interferon-free therapy for Genotype 1 Hepatitis C in our hospita","subitem_title_language":"en"}]},"item_type_id":"2","owner":"14","path":["2066"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-04-08"},"publish_date":"2019-04-08","publish_status":"0","recid":"13972","relation_version_is_last":true,"title":["当院におけるGenotype1b 型Ｃ型慢性肝疾患に対するインターフェロンフリー療法の治療成績"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T03:03:11.939271+00:00"}